Based on recent data, Oruka Therapeutics, Inc. (ORKA) shows an Average True Range (ATR) of 1.96 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 1.14M, indicating liquidity. These fundamental metrics provide insight into ORKA's underlying financial health and market activity.
| ATR | 1.96 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 1.14M |
| Avg Vol (10 Days) | 631.66K |
Oruka Therapeutics, Inc. (ORKA) technical indicators as of September 12, 2026: the SMA 20 is 2.88%, SMA 50 at 7.38%, and SMA 200 at 57.69%. The RSI 14 value is 56.41, suggesting its current momentum. These technical analysis signals help assess ORKA's price trends and potential future movements.
| SMA 20 | 2.88% |
| SMA 50 | 7.38% |
| SMA 200 | 57.69% |
| RSI 14 | 56.41 |
Oruka Therapeutics, Inc. (ORKA) stock performance overview as of September 12, 2026: The 52-week high is $115.52 (currently -6.05% below), and the 52-week low is $14.67 (currently 525.71% above). Over the past year, ORKA's performance is 163.73%, compared to the S&P 500's 0.26% change.
| 52-Week High | 115.52 |
| 52-Week High Chg | -6.05% |
| 52-Week Low | 14.67 |
| 52-Week Low Chg | +525.71% |
| S&P 500 52-Week Chg | 0.26% |
According to market data, Oruka Therapeutics, Inc. (ORKA) stock's recent performance metrics show that over the last month, ORKA is 17.09%, with a Year-to-Date (YTD) performance of 9.63%. Over the past year, the stock has seen a 163.73% change. These figures summarize ORKA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 96.44 | 115.52 | 115.52 | 115.52 | 115.52 | 115.52 |
| Low | 87.68 | 86 | 66.68 | 31.32 | 14.67 | 25.23 |
| Performance | +8.28% | +17.09% | +20.92% | +141.32% | +163.73% | +9.63% |
According to current financial data, ORKA stock's P/E (TTM) ratio is -37.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for ORKA, including P/S (N/A), P/B (5.23), and P/FCF (-55.26), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ORKA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -37.52 | -1.25 | -194.38 | 32.59 |
| P/S (TTM) | N/A | 3.74 | 467.58 | 5.98 |
| P/B (TTM) | 5.23 | 1.14 | 15.86 | 5.59 |
| P/FCF (TTM) | -55.26 | -1.34 | -698.52 | 28.73 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep